Products

Clinically shown, human milk–based nutrition

More than 70,000 premature infants throughout the world have experienced proven clinical benefits from Prolacta’s 100% human milk–based nutritional products.¹

Improve health outcomes²^,³^,⁴^,⁵^,⁶^,⁷ including:

Bronchopulmonary dysplasia (BPD)⁸^,⁹^,⁵^,⁶
Late-onset sepsis⁸^,⁵^,⁷
Retinopathy of prematurity (ROP)⁸^,⁵^,⁶
Necrotising enterocolitis (NEC)⁶^,²^,⁵

When used as part of an exclusive human milk diet (EHMD) as compared to cow milk–based products, Prolacta’s products have been shown in clinical studies to:

Achieve adequate growth⁹^,¹⁰^,¹¹
Reduce feeding intolerance⁶
Lower incidence of mortality and morbidity³^,⁴^,⁵
Shorten neonatal intensive care unit (NICU) stays⁶
Reduce hospital costs⁶^,¹²

Clinical evidence

Premature infant nutrition

Fortifier

Supplementing mother’s own milk (MOM) with the first commercially available human milk–based fortifier made from 100% human donor milk instead of cow milk

Caloric fortifier

When premature infants need additional calories to support their growth, this human milk–based caloric fortifier delivers

Ready-to-feed

This ready-to-feed, human milk–based product offers NICUs an alternative to cow milk-based formula when mother’s own milk (MOM) is not available

Adequately nourishing infants with mother’s own milk (MOM) fortified with human milk–based products

Since 2012, the American Academy of Pediatrics (AAP) has recommended human milk for preterm infants, whether mother’s own milk (MOM) or pasteurised donor human milk if mother’s own milk (MOM) is unavailable. For those infants born weighing less than 1.500 kg, the American Academy of Pediatrics (AAP) recommends fortifying mother’s own milk (MOM) or donor human milk with protein and minerals to ensure optimal nutrient intake.¹³ Our products help hospitals meet the nutritional needs of their medically fragile patients in the Special Care Baby Unit (NICU).

Made with lab-tested donor milk in US Food and Drug Administration (FDA) regulated manufacturing facilities

Hospitals choose Prolacta’s 100% human milk–based nutritional products for the assurance that they are receiving safe, standardised donor milk formulations processed in a pharmaceutical-grade facility under the strictest quality and safety guidelines to protect the health and well-being of their most fragile patients¹.

Our process

A cost-effective solution

When used as part of an exclusive human milk diet (EHMD), our human milk–based nutritional products are clinically shown to increase survival and reduce the overall cost of care compared to cow milk–based fortifier or preterm formula in extremely premature infants. ⁴^, ⁵

Tell us how we can help

Clinician-to-clinician guidance

Coding, billing and reimbursement questions

Finding my sales representative

Support with an order